Spirapril

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
Spirapril
(IUPAC) ime
(8S)-7-[(2S)-2- {[(2S)-1-etoksi-1-okso-4-fenilbutan-2-il]amino}propanoil]-1,4-ditia-7-azaspiro[4.4]nonan-8-karboksilna kiselina
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 83647-97-6
ATC kod C09AA11
PubChem[1][2] 5311447
DrugBank DB01348
ChemSpider[3] 4470933
UNII 96U2K78I3V YesY
KEGG[4] D08529 YesY
ChEMBL[5] CHEMBL431 YesY
Hemijski podaci
Formula C22H30N2O5S2 
Mol. masa 466,616 g/mol
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Bioraspoloživost 50%
Metabolizam konvertuje se u spiraprilat
Poluvreme eliminacije 30 do 35 sati
Izlučivanje Hepatički i renalno
Farmakoinformacioni podaci
Trudnoća ?
Pravni status Prescription only
Način primene Oralno

Spirapril hidrohlorid (Renormax) je ACE inhibitor antihipertenzivni lek koji se koristi u tretmanu hipertenzije. On pripada dikarboksilnoj grupi ACE inhibitora.

Poput mnogih ACE inhibitora, ovaj lek je prolek koji se konvertuje do aktivnog metabolita spiraprilata nakon oralne administracije. Za razliku od drugih članova grupe, on se eliminiše renalnim i hepatičkim putem, te je podesniji za primenu kod pacijenata sa renalnim oštećenjima.[6][7]

Osobine[uredi - уреди | uredi izvor]

Osobina Vrednost
Broj akceptora vodonika 8
Broj donora vodonika 2
Broj rotacionih veza 10
Particioni koeficijent[8] (ALogP) 0,3
Rastvorljivost[9] (logS, log(mol/L)) -5,4
Polarna površina[10] (PSA, Å2) 146,5

Reference[uredi - уреди | uredi izvor]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). "PubChem as a public resource for drug discovery.". Drug Discov Today 15 (23-24): 1052–7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). "Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities". Annual Reports in Computational Chemistry 4: 217–241. doi:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). "Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining". J Cheminform 2 (1): 3. PMID 20331846. doi:10.1186/1758-2946-2-3.  edit
  4. Joanne Wixon, Douglas Kell (2000). "Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG". Yeast 17 (1): 48–55. doi:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). "ChEMBL: a large-scale bioactivity database for drug discovery". Nucleic Acids Res 40 (Database issue): D1100–7. PMID 21948594. doi:10.1093/nar/gkr777.  edit
  6. Shohat J, Wittenberg C, Erman A, Rosenfeld J, Boner G (1999). "Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.". Scand J Urol Nephrol 33 (1): 57–62. PMID 10100366. doi:10.1080/003655999750016294. 
  7. Noble S, Sorkin E (1995). "Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.". Drugs 49 (5): 750–66. PMID 7601014. 
  8. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). "Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods". J. Phys. Chem. A 102: 3762–3772. doi:10.1021/jp980230o. 
  9. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). "Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices". Chem Inf. Comput. Sci. 41: 1488–1493. PMID 11749573. doi:10.1021/ci000392t.  edit
  10. Ertl P., Rohde B., Selzer P. (2000). "Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties". J. Med. Chem. 43: 3714–3717. PMID 11020286. doi:10.1021/jm000942e.  edit

Literatura[uredi - уреди | uredi izvor]

Spoljašnje veze[uredi - уреди | uredi izvor]

Star of life.svg Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini).